These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12911724)

  • 1. Alterations of the P16 gene in uterine cervical carcinoma from Indian patients.
    Tripathi A; Banerjee S; Roy A; Roychowdhury S; Panda CK
    Int J Gynecol Cancer; 2003; 13(4):472-9. PubMed ID: 12911724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of p16 and p15 genes in human uterine tumours.
    Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
    Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
    Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
    Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 8. The relevance of oncogenes as prognostic markers in cervical cancer.
    Soh LT; Heng D; Lee IW; Ho TH; Hui KM
    Int J Gynecol Cancer; 2002; 12(5):465-74. PubMed ID: 12366664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylation and aberrant expression of the p16 gene in cervical carcinoma].
    Yuan JR; Li Y; Hu SJ; Li P
    Yi Chuan; 2005 Jan; 27(1):39-43. PubMed ID: 15730957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.
    Thakur N; Hussain S; Nasare V; Das BC; Basir SF; Bharadwaj M
    Mol Biol Rep; 2012 Jan; 39(1):407-14. PubMed ID: 21567202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study.
    Park JS; Dong SM; Kim HS; Lee JY; Um SJ; Park IS; Kim SJ; Namkoong SE
    Cancer Lett; 1999 Feb; 136(1):101-8. PubMed ID: 10211947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
    Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S
    Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
    Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
    Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
    Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
    Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.
    Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Gandhi G; Rizvi MMA
    Tumour Biol; 2017 Jun; 39(6):1010428317703635. PubMed ID: 28631565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
    Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
    Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of epigenetic alterations and in silico analysis of mutation affecting PTEN expression among Indian cervical cancer patients.
    Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Bin Hafeez Z; Tiwari RR; Wahabi K; Gandhi G; Alam Rizvi MM
    J Cell Biochem; 2019 Sep; 120(9):15851-15866. PubMed ID: 31074114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
    Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
    J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.